Healthcare -
Biotechnology - NASDAQ - US
$ 13.61
3.34 %
$ 1.54 B
Market Cap
-4.04
P/E
DYN - RESEARCH & DEVELOPMENT
Research & Development DYN - Dyne Therapeutics, Inc.
211 M
LAST VALUE
31.81%
2 YEAR CAGR
118.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR